Market Currents
Biopharmaceutical company Ziopharm Oncology (ZIOP -5.5%) says it plans to sell an undisclosed...
-
Friday, January 20, 2012, 3:41 PM ETBiopharmaceutical company Ziopharm Oncology (ZIOP -5.5%) says it plans to sell an undisclosed number of shares of common stock to fund the development of its drug candidates, as well as for general corporate and working capital purposes.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
